News & Events

Experts wrestle with today’s tough biotechnology questions at third Arizona Biosecurity Workshop

December 18, 2018

Given the enormous attention recently trained on a Chinese scientist who performed a gene editing experiment on human twins, interest in scientific protocol, responsibility and biosecurity is at an all-time high. Attendance at the third annual Arizona Biosecurity Workshop, held at Arizona State University, Dec. 13 and 14 was certainly evidence of the fierce current debate. At the event, the biggest questions revolved around the threats, opportunities and responsibilities tied to emerging...

Escape from the lab! Six promising biotech start-up companies profiled at all-day symposium

October 1, 2018

  ASU’s many laboratories are seedbeds for an astonishing variety of new ideas. But the path from basic research to real-world applications can be complex, perilous and sometimes, bewildering. Recently, an all-day seminar, hosted at the Biodesign Institute, explored an array of promising research that has escaped the confines of the lab. New spinout companies, based on pathbreaking research, are bringing exciting innovations in the life sciences to market. The gathering was...

Study investigates new weapons against African swine fever

February 21, 2018

African swine fever is a highly contagious, viral infection affecting pigs. It has devastated domestic herds in many regions and brought economic hardship. The rapid spread of this disease has become a serious concern to wildlife biologists and veterinarians. No adequate vaccine exists to protect against African Swine Fever Virus (ASFV), the cause of this ailment, and efforts to arrest the spread of ASFV have been largely ineffective. In a new study, researchers from Arizona State...

ASU alumna uses her love of science to improve the lives of patients

January 11, 2018

A research project, personal experience or academic course often drives students into a particular field of study. For Arizona State University alumna Teresa Brandt, it was her inherent curiosity that led her to study molecular and cellular biology. “I’m very curious and this field has allowed me to explore my curiosity in science,” Brandt said. “Exploring science and being a role model for my family and my kids in doing a job that’s meaningful and rewarding drives me to stay in...

ASU faculty find kindred community of educators in a far-off land

July 12, 2017

Lindy Elkins-Tanton, Bert Jacobs lead 2-day teachers' workshop in Tanzania to help create students passionate about learning Sometimes Arizona State University’s mission is carried out far beyond the boundaries of campus. This summer two ASU faculty members — Lindy Elkins-Tanton, director of the School of Earth and Space Exploration, and Bert Jacobs, director of the School of Life Sciences — went to Tanzania, where they led a team conducting a two-day teaching workshop for...

ASU professor on progress toward an HIV/AIDS vaccine

November 17, 2015

After the announcement by actor Charlie Sheen that he is HIV positive, ASU Now asks how far away we are from a vaccine. The actor Charlie Sheen announced Tuesday that he is HIV positive. He said in an interiew on NBC News that he was diagnosed four years ago. According to the World Health Organization, nearly 78 million people have been infected with the HIV virus and about 39 million people have died of HIV since the beginning of the epidemic in the 1980s.  Globally, an estimated 35...

Future flu: Where the annual shot is heading

October 12, 2015

With signs for flu shots festooning grocery stores, clinics and HR departments, the onset of flu season is heralded with as much fervor — if less enthusiasm — than Christmas. Part of this is because the old days of vaccines meant getting mildly to very sick after being immunized, but still feeling better than getting the actual virus. “You could give it to a human, get a mild disease and be immunized,” said Bertram Jacobs, a professor of virology in the Center for Infectious...

The Variable Vaccine for HIV

October 11, 2012

Over 33 million people worldwide are infected with human immunodeficiency virus (HIV), and the race for a cure has, it seems, turned into a marathon. Though the road has been long, Bertram Jacobs, a virologist at Arizona State University, has achieved promising results in his efforts to develop an HIV vaccine. While Jacobs doesn’t deal in cures, his work has two main goals: the creation of a vaccine that can prevent infection or extend the life of HIV patients, and successful...

Biodesign researcher, graduate student receive Fulbright honors

July 2, 2012

Bert Jacobs, Professor in the School of Life Sciences and the Center for Infectious Diseases and Vaccinology in the Biodesign Institute at Arizona State University, has been selected for a Fulbright Specialist’s project in the Republic of South Africa at the University of Cape Town during July 2012, according to the United States Department of State and the J. William Fulbright Foreign Scholarship Board. Professor Jacobs will provide lectures on the prospects for an HIV vaccine in the near...

Biodesign Institute's Bert Jacobs Named Academia Winner at 2006 Governor’s Celebration of Innovation Awards Event

December 6, 2006

Biodesign Institute virologist Bert Jacobs was named the recipient of the Innovator of the Year Award for Academia at the Governor’s Celebration of Innovation Awards, held before a packed house at the Point South Mountain Resort on December 5, 2006. “I’m a professor and am usually not at a loss for words, but this is pretty amazing,” said Jacobs, upon accepting the award. Jacobs dedicated the honor to his two daughters, who were present at the event, for “putting up with the weird...